# Study of Topical SOR007 Ointment for Cutaneous Metastases

> **NCT03101358** · PHASE1,PHASE2 · COMPLETED · sponsor: **NanOlogy, LLC** · enrollment: 23 (actual)

## Conditions studied

- Cutaneous Metastasis

## Interventions

- **DRUG:** SOR007 (Uncoated Nanoparticle Paclitaxel) Ointment

## Key facts

- **NCT ID:** NCT03101358
- **Lead sponsor:** NanOlogy, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-31
- **Primary completion:** 2020-04-29
- **Final completion:** 2020-04-29
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2021-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03101358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03101358, "Study of Topical SOR007 Ointment for Cutaneous Metastases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03101358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*